Matches in Wikidata for { <http://www.wikidata.org/entity/Q66346181> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q66346181 description "clinical trial" @default.
- Q66346181 description "ensayu clínicu" @default.
- Q66346181 description "klinisch onderzoek" @default.
- Q66346181 description "клінічне випробування" @default.
- Q66346181 name "Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents." @default.
- Q66346181 name "Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents." @default.
- Q66346181 type Item @default.
- Q66346181 label "Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents." @default.
- Q66346181 label "Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents." @default.
- Q66346181 prefLabel "Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents." @default.
- Q66346181 prefLabel "Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents." @default.
- Q66346181 P1050 Q66346181-F6A1C39D-551C-45BE-B86C-1C825396EDE5 @default.
- Q66346181 P1132 Q66346181-E001D79C-C00D-43AA-99D9-88813DEF3C24 @default.
- Q66346181 P1476 Q66346181-9F39847C-2D4B-4018-A758-6374BBFCB049 @default.
- Q66346181 P17 Q66346181-09D24AA0-B1CE-4D86-951A-80D218835703 @default.
- Q66346181 P17 Q66346181-0DCC2BA6-D3E4-47B3-9907-9585B2BFECF2 @default.
- Q66346181 P17 Q66346181-257C0A03-2099-4EAD-BC1F-20A08DDA6A62 @default.
- Q66346181 P17 Q66346181-46A55765-6C71-4906-8848-12CDA702EC01 @default.
- Q66346181 P17 Q66346181-67686C7B-FA16-4BE8-8641-4AAF1924CB6D @default.
- Q66346181 P17 Q66346181-6EBBEEED-176F-470C-A05F-9151F389F112 @default.
- Q66346181 P17 Q66346181-7218D5E0-3C74-409D-BC9F-646279EFECD3 @default.
- Q66346181 P17 Q66346181-75F0128A-6273-4275-8A7D-7F1C0C8B9737 @default.
- Q66346181 P17 Q66346181-7800EE46-CA3B-4959-9CBD-907B02415E67 @default.
- Q66346181 P17 Q66346181-8BF22D3B-188E-47A4-BABF-F9E17CB9432C @default.
- Q66346181 P17 Q66346181-994E2000-861B-4D7E-B0E0-D6A19DC89340 @default.
- Q66346181 P17 Q66346181-BCB1AC4E-96A6-4ACF-962F-D5E0102FE2C5 @default.
- Q66346181 P17 Q66346181-C967B658-D601-4846-ACC5-5BBE4F54EDCA @default.
- Q66346181 P17 Q66346181-EFDFFB4C-BEEC-41FD-99A1-7FBB01350A62 @default.
- Q66346181 P17 Q66346181-F940972E-573D-4E31-BC5B-B4363639A9FC @default.
- Q66346181 P1813 Q66346181-20B0A022-BAC1-4A0F-84C2-2A85118F97CB @default.
- Q66346181 P2899 Q66346181-FFB55D88-59F0-4560-A17D-341AF9D3DFCD @default.
- Q66346181 P3098 Q66346181-3DE3D534-1B7D-4634-ABF8-66E40C653197 @default.
- Q66346181 P31 Q66346181-F560BC8B-D959-45FC-B570-BD3F2834EA68 @default.
- Q66346181 P580 Q66346181-F458049A-05C0-4BEE-83E2-99FD025EFE9A @default.
- Q66346181 P582 Q66346181-F5D1BCF6-DBAE-4CBA-938D-2A367CFC9C61 @default.
- Q66346181 P6099 Q66346181-8F921E22-244F-44BD-8E57-F5191BA6E391 @default.
- Q66346181 P8363 Q66346181-962F2949-2F4B-4878-B7A0-84EB1D480BF3 @default.
- Q66346181 P859 Q66346181-3DA9315C-3175-4350-A25A-166D88A04EDD @default.
- Q66346181 P1050 Q170990 @default.
- Q66346181 P1132 "+242" @default.
- Q66346181 P1476 "A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate the Efficacy at 24 Weeks and to Assess the Long Term Efficacy, Safety, Tolerability and Usability up to 5 Years in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNFα Agents" @default.
- Q66346181 P17 Q155 @default.
- Q66346181 P17 Q17 @default.
- Q66346181 P17 Q183 @default.
- Q66346181 P17 Q213 @default.
- Q66346181 P17 Q258 @default.
- Q66346181 P17 Q30 @default.
- Q66346181 P17 Q38 @default.
- Q66346181 P17 Q41 @default.
- Q66346181 P17 Q414 @default.
- Q66346181 P17 Q45 @default.
- Q66346181 P17 Q668 @default.
- Q66346181 P17 Q739 @default.
- Q66346181 P17 Q774 @default.
- Q66346181 P17 Q786 @default.
- Q66346181 P17 Q804 @default.
- Q66346181 P1813 "REASSURE2" @default.
- Q66346181 P2899 "+18" @default.
- Q66346181 P3098 "NCT01770379" @default.
- Q66346181 P31 Q30612 @default.
- Q66346181 P580 "2012-10-01T00:00:00Z" @default.
- Q66346181 P582 "2015-05-01T00:00:00Z" @default.
- Q66346181 P6099 Q42824827 @default.
- Q66346181 P8363 Q78089383 @default.
- Q66346181 P859 Q507154 @default.